Marker Therapeutics is trading at $1.24, up 5.57% in pre-market on September 16, 2026, after rising from the September 15 close of $1.17.
- No fresh company-specific announcement, earnings release, or filing dated September 15–16 was identified; the latest listed filing was August 14.
- Broader indexes were modestly higher, below the threshold for a strong market-wide explanation; activity and volume data were unavailable.